Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease
Journal Article
·
· J. Natl. Cancer Inst.; (United States)
OSTI ID:6723131
In a population of 334 patients treated for Hodgkin's disease by the European Organization for Research and Treatment of Cancer between 1964 and 1971, 21 patients with second primary cancers (SC) were observed: 4 patients with acute leukemias, 3 with non-Hodgkin's lymphomas, and 14 with solid tumors. Time to SC ranged from 2 to 16 years after initial treatment. The relative risk (RR) of acute leukemia for the patients with Hodgkin's disease as compared to the general population was 40. The RR of leukemia in patients treated by polychemotherapy--mechlorethamine, vincristine, procarbazine, and prednisone--for relapse was 300. However, the RR of leukemia for those patients who did not experience a relapse was 14 (not significant). The RR of other SC in the overall group was 3.76. For patients whose relapses were treated by polychemotherapy the RR of SC, leukemia excepted, was 26, whereas for patients not treated by polychemotherapy for relapse the RR was slightly increased. The cumulative proportions of acute leukemia at 10 years were 0.7% in the ''no-relapse'' group and 2.7% in the polychemotherapy group. The cumulative proportions of other SC at 10 years was 1.3% in the no-relapse group, 7.2% in the group of patients not treated by polychemotherapy after relapse, and 8.4% in the polychemotherapy group. The first important risk factor for developing an SC was polychemotherapy, and the second was age over 40 years. These data suggest that combination chemotherapy may be responsible for both acute leukemias and other SC.
- Research Organization:
- Unite de Recherches Statistiques--INSERM, Villejuif, France
- OSTI ID:
- 6723131
- Journal Information:
- J. Natl. Cancer Inst.; (United States), Journal Name: J. Natl. Cancer Inst.; (United States) Vol. 71:5; ISSN JNCIA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Second acute leukemia and other malignancies following treatment for Hodgkin's disease
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study
Hodgkin's disease with leptomeningeal involvement. Report of a case with long survival
Journal Article
·
Sun Jun 01 00:00:00 EDT 1986
· J. Clin. Oncol.; (United States)
·
OSTI ID:5231087
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study
Journal Article
·
Thu Feb 28 23:00:00 EST 1991
· Journal of Clinical Oncology; (USA)
·
OSTI ID:5952633
Hodgkin's disease with leptomeningeal involvement. Report of a case with long survival
Journal Article
·
Tue May 01 00:00:00 EDT 1984
· Cancer (Philadelphia); (United States)
·
OSTI ID:6945180
Related Subjects
560151* -- Radiation Effects on Animals-- Man
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CHEMOTHERAPY
DELAYED RADIATION EFFECTS
DISEASES
HEMIC DISEASES
HODGKINS DISEASE
LEUKEMIA
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PATIENTS
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
THERAPY
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CHEMOTHERAPY
DELAYED RADIATION EFFECTS
DISEASES
HEMIC DISEASES
HODGKINS DISEASE
LEUKEMIA
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PATIENTS
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
SIDE EFFECTS
THERAPY